semaglutide medicine in Winter Garden Ozempic® (semaglutide) GLP-1 RA for

In December 2025, the Food and Drug Administration (FDA) approved an oral pill form of Wegovy for weight loss, and in April 2026 approved the once-daily oral GLP-1 drug Foundayo (orforglipron) also for weight loss

(2024) provided insights into the genetic and non-genetic mechanisms governing cancer cell dormancy, highlighting both the complexity and cancer type-specificity of this phenomenon

EMA (2014)

Low vitamin B-12 status and risk of cognitive decline in older adults

Association of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and neurogenesis: a systematic review

This share is attributed to the growing government support for domestic manufacturing, which is likely to boost the production levels and reduce the dependence on imports in the Asia Pacific region, thereby offering lucrative opportunities to global manufacturers